Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Post by narmacon Dec 15, 2022 9:55am
146 Views
Post# 35172966

When to buy???

When to buy???Just thinking when to buy if one still likes the path forward,,,, I am thinking after Biodexa sets its course on the NASDAQ,,,,but and its a big but,, based on what we see from the markets reaction to this merger we will be back to the ADR system and then as time rolls on we get reverse splits and dilution once again over the next 12-18 months. That would be extremely ugly for any respectable share price and market cap,,,comments????

<< Previous
Bullboard Posts
Next >>